Tags Intellectual Property

Keyword: Intellectual Property

What LDC graduation will mean for Bangladesh’s drugs industry

  Bangladesh’s pharmaceutical industry is unique among least developed countries (LDCs). Driven by active government policies, output has grown a thousand times since 1982, to...

Provisions for LDCs in the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS...

The TRIPS Agreement covers copyright and related rights (i.e. the rights of performers, producers of sound recordings and broadcasting organizations); trademarks including service marks; geographical indications including appellations of origin; industrial designs;...

TRIPS Agreement: waiver from notification requirements for issuing compulsory licenses for exports of pharmaceutical...

Article 31(f) of the TRIPS Agreement states products made under compulsory licensing must be "predominantly for the supply of the domestic market". Paragraph 6...

TRIPS Agreement: Technology transfer (Art. 66.2)

Under Article 66.2 of the TRIPS Agreement, developed country Members shall provide incentives to enterprises and institutions in their territories for the purpose of...

TRIPS Agreement: Transitional period for pharmaceutical products

LDC members of the WTO are not obliged to protect pharmaceutical patents until 1 January 2033 (TRIPS Council decision, 6 November 2015, IP/C/73). Non-LDC developing...

TRIPS Agreement: Transitional period for implementing the Agreement (Article 66.1)

LDCs were not required to implement the TRIPS Agreement, other than Article 3 (national treatment), Article 4 (MFN treatment) and Article 5 (precedence of...

WIPO LDC country profiles

WIPO provides LDC-specific intellectual property profiles for all LDCs. The profiles can be accessed directly from the WIPO website. See also information about WIPO support...

WTO drugs patent waiver for LDCs extended until 2033

On 6 November 2015, the World Trade Organization (WTO) Council decided to extend the exemption for LDC WTO members to implement provisions of the TRIPS agreement...

Global experts letter on LDC extension of transition period in TRIPS Agreement

(May 2013) Over 130 academics from around the world have signed a letter supporting the unconditional extension of the transition period within which Least...

Medecins Sans Frontieres and LDCs

(Archives, May 2013) Medecins Sans Frontiers (MSF) is voicing its support to the extension of the transition period for the Least Developed Countries (LDCs)...

UNAIDS and UNDP on the extension of TRIPS transition period for LDCs

On 26 February 2013, the joint United Nations Programme on HIV/AIDS (UNAIDS) and United Nations Developed Program (UNDP) and  published a Issue Brief on TRIPS trasition...